Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM (2011) Phage treatment of human infections. Bacteriophage 1:66–85 . https://doi.org/10.4161/bact.1.2.15845
Adams M (1959) Assay of phages by the agar layer method. In: Bacteriophages. Interscience Publishers, pp 450–451
Aleshkin A, Ershova O, Volozhantsev N, Svetoch E, Rubalsky E, Borzilov A, Aleshkin V, Afanasiev S, Bochkareva S (2016) Phagebiotics in treatment and prophylaxis of healthcareassociated infections. In: Bacteriophages: An Overview and Synthesis of a Re-Emerging Field. Nova Science Publishers, Inc., pp 105–122
Anand T, Virmani N, Kumar S, Mohanty AK, Pavulraj S, Bera BC, Vaid RK, Ahlawat U, Tripathi BN (2020) Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model. J Glob Antimicrob Resist 21:34–41 . https://doi.org/10.1016/j.jgar.2019.09.018
Andrews JM, Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemother 48 Suppl 1:5–16 . https://doi.org/10.1093/jac/48.suppl_1.5
Basu S, Agarwal M, Bhartiya SK, Nath G, Shukla VK (2015) An in vivo wound model utilizing bacteriophage therapy of pseudomonas aeruginosa biofilms. Ostomy Wound Manag 61:16–23
Blander JM, Longman RS, Iliev ID, Sonnenberg GF, Artis D (2017) Regulation of inflammation by microbiota interactions with the host. Nat. Immunol. 18:851–860
Bonilla N, Rojas MI, Cruz GNF, Hung SH, Rohwer F, Barr JJ (2016) Phage on tap-a quick and efficient protocol for the preparation of bacteriophage laboratory stocks. PeerJ 2016:e2261 . https://doi.org/10.7717/peerj.2261
Burmeister AR, Fortier A, Roush C, Lessing AJ, Bender RG, Barahman R, Grant R, Chan BK, Turner PE (2020) Pleiotropy complicates a trade-off between phage resistance and antibiotic resistance. Proc Natl Acad Sci 201919888 . https://doi.org/10.1073/pnas.1919888117
Cao F, Wang X, Wang L, Li Z, Che J, Wang L, Li X, Cao Z, Zhang J, Jin L, Xu Y (2015) Evaluation of the Efficacy of a Bacteriophage in the Treatment of Pneumonia Induced by Multidrug Resistance Klebsiella pneumoniae in Mice. Biomed Res Int 2015:752930 . https://doi.org/10.1155/2015/752930
Capparelli R, Parlato M, Borriello G, Salvatore P, Iannelli D (2007) Experimental phage therapy against Staphylococcus aureus in mice. Antimicrob Agents Chemother 51:2765–2773 . https://doi.org/10.1128/AAC.01513-06
Chan BK, Sistrom M, Wertz JE, Kortright KE, Narayan D, Turner PE (2016) Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci Rep 6:1–8 . https://doi.org/10.1038/srep26717
Chhibber S, Bansal S, Kaur S (2015) Disrupting the mixed-species biofilm of klebsiella pneumoniae B5055 and pseudomonas aeruginosa PAO using bacteriophages alone or in combination with xylitol. Microbiol (United Kingdom) 161:1369–1377 . https://doi.org/10.1099/mic.0.000104
Chhibber S, Kaur S, Kumari S (2008) Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. J Med Microbiol 57:1508–13 . https://doi.org/10.1099/jmm.0.2008/002873-0
Christena LR, Raman T, Makala VH, Ulaganathan V, Subramaniapillai S (2016) Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail Multi Drug Resistant clinical isolate of MRSA in a zebra fish infection model . Appl Microbiol Biotechnol. https://doi.org/10.1007/s00253-016-7759-2
Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF, Melton DM, Beachey EH (1985) Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 22:996–1006 . https://doi.org/10.1128/jcm.22.6.996-1006.1985
Domingo-Calap P, Beamud B, Vienne J, González-Candelas F, Sanjuán R (2020) Isolation of four lytic phages infecting Klebsiella pneumoniae K22 clinical isolates from Spain. Int J Mol Sci 21: . https://doi.org/10.3390/ijms21020425
Dwivedi B, Schmieder R, Goldsmith DB, Edwards RA, Breitbart M (2012) PhiSiGns: An online tool to identify signature genes in phages and design PCR primers for examining phage diversity. BMC Bioinformatics 13:37 . https://doi.org/10.1186/1471-2105-13-37
German GJ, Misra R (2001) The TolC protein of Escherichia coli serves as a cell-surface receptor for the newly characterized TLS bacteriophage. J Mol Biol 308:579–585 . https://doi.org/10.1006/jmbi.2001.4578
Grillon A, Schramm F, Kleinberg M, Jehl F (2016) Comparative activity of ciprofloxacin, levofloxacin and moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia assessed by minimum inhibitory concentrations and time-kill studies. PLoS One 11:1–10 . https://doi.org/10.1371/journal.pone.0156690
Holst Sørensen MC, van Alphen LB, Fodor C, Crowley SM, Christensen BB, Szymanski CM, Brøndsted L (2012) Phase variable expression of capsular polysaccharide modifications allows Campylobacter jejuni to avoid bacteriophage infection in chickens. Front Cell Infect Microbiol 2:11 . https://doi.org/10.3389/fcimb.2012.00011
Hoyles L, Murphy J, Neve H, Heller KJ, Turton JF, Mahony J, Sanderson JD, Hudspith B, Gibson GR, McCartney AL, van Sinderen D (2015) Klebsiella pneumoniae subsp. pneumoniae-bacteriophage combination fromthe caecal effluent of a healthy woman. PeerJ 2015: . https://doi.org/10.7717/peerj.1061
Investigators of the Delhi Neonatal Infection Study (DeNIS) collaboration (2016) Characterisation and antimicrobial resistance of sepsis pathogens in neonates born in tertiary care centres in Delhi, India: a cohort study. Lancet Glob Heal 4:e752–e760 . https://doi.org/10.1016/S2214-109X(16)30148-6
Jarvis WR, Munn VP, Highsmith AK, Culver DH, Hughes JM (1985) The epidemiology of nosocomial infections caused by Klebsiella pneumoniae. Infect. Control 6:68–74
Kęsik-Szeloch A, Drulis-Kawa Z, Weber-Dąbrowska B, Kassner J, Majkowska-Skrobek G, Augustyniak D, Lusiak-Szelachowska M, Zaczek M, Górski A, Kropinski AM (2013) Characterising the biology of novel lytic bacteriophages infecting multidrug resistant Klebsiella pneumoniae. Virol J 10:100 . https://doi.org/10.1186/1743-422X-10-100
Khairnar K (2016) Ganges: Special at its origin. J. Biol. Res. 23:16
Kumari S, Harjai K, Chhibber S (2011) Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055. J Med Microbiol 60:205–210 . https://doi.org/10.1099/jmm.0.018580-0
Lieschke GJ, Currie PD (2007) Animal models of human disease: Zebrafish swim into view. Nat. Rev. Genet. 8:353–367
Lin T-L, Hsieh P-F, Huang Y-T, Lee W-C, Tsai Y-T, Su P-A, Pan Y-J, Hsu C-R, Wu M-C, Wang J-T (2014) Isolation of a bacteriophage and its depolymerase specific for K1 capsule of Klebsiella pneumoniae: implication in typing and treatment. J Infect Dis 210:1734–1744 . https://doi.org/10.1093/infdis/jiu332
Malik R, Chhibber S (2009) Protection with bacteriophage KØ1 against fatal Klebsiella pneumoniae-induced burn wound infection in mice. J Microbiol Immunol Infect 42:134–140
Manohar P, Tamhankar AJ, Lundborg CS, Nachimuthu R (2019) Therapeutic Characterization and Efficacy of Bacteriophage Cocktails Infecting Escherichia coli, Klebsiella pneumoniae, and Enterobacter Species. Front Microbiol 10:574 . https://doi.org/10.3389/fmicb.2019.00574
Merritt JH, Kadouri DE, O’Toole GA (2005) Growing and Analyzing Static Biofilms. In: Current Protocols in Microbiology. John Wiley & Sons, Inc., p Unit 1B.1
Monferrer E, Domingo-Calap P (2019) Virus-Host Coevolution as a Tool for Controlling Bacterial Resistance to Phage Therapy. J Biotechnol Biomed 02: . https://doi.org/10.26502/jbb.2642-91280013
Neely M, Pfeifer J, Caparon M (2002) Streptococcus-zebrafish model of bacterial pathogenesis. Infect Immun 70:3904–3914 . https://doi.org/10.1128/IAI.70.7.3904
Novince CM, Whittow CR, Aartun JD, Hathaway JD, Poulides N, Chavez MB, Steinkamp HM, Kirkwood KA, Huang E, Westwater C, Kirkwood KL (2017) Commensal Gut Microbiota Immunomodulatory Actions in Bone Marrow and Liver have Catabolic Effects on Skeletal Homeostasis in Health. Sci Rep 7:5747 . https://doi.org/10.1038/s41598-017-06126-x
Oliveira H, Mendes A, Fraga AG, Ferreira A, Pimenta AI, Mil-Homens D, Fialho AM, Pedrosa J, Azeredo J (2019) K2 capsule depolymerase is highly stable, is refractory to resistance, and protects larvae and mice from Acinetobacter baumannii sepsis. Appl Environ Microbiol 85: . https://doi.org/10.1128/AEM.00934-19
Pajunen M, Kiljunen S, Skurnik M (2000) Bacteriophage phiYeO3-12, specific for Yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7. J Bacteriol 182:5114–20 . https://doi.org/10.1128/jb.182.18.5114-5120.2000
Pan Y-J, Lin T-L, Chen C-C, Tsai Y-T, Cheng Y-H, Chen Y-Y, Hsieh P-F, Lin Y-T, Wang J-T (2017) Klebsiella Phage ΦK64-1 Encodes Multiple Depolymerases for Multiple Host Capsular Types. J Virol 91: . https://doi.org/10.1128/jvi.02457-16
Phillips JB, Westerfield M (2014) Zebrafish models in translational research: Tipping the scales toward advancements in human health. DMM Dis Model Mech 7:739–743 . https://doi.org/10.1242/dmm.015545
Sasani MS, Fereshteh Eftekhar · (2020) Potential of a Bacteriophage Isolated from Wastewater in Treatment of Lobar Pneumonia Infection Induced by Klebsiella pneumoniae in Mice. https://doi.org/10.1007/s00284-020-02041-z
Shi Y, Chen Y, Yang Z, Zhang Y, You B, Liu X, Chen P, Liu M, Zhang C, Luo X, Chen Y, Yuan Z, Chen J, Gong Y, Peng Y (2020) Characterization and genome sequencing of a novel T7-like lytic phage, kpssk3, infecting carbapenem-resistant Klebsiella pneumoniae. Arch Virol 165:97–104 . https://doi.org/10.1007/s00705-019-04447-y
Sulakvelidze A, Alavidze Z, Morris J (2001) Bacteriophage therapy. Antimicrob. Agents Chemother. 45:649–659
Summers WC (2012) The strange history of phage therapy. Bacteriophage 2:130–133 . https://doi.org/10.4161/bact.20757
Tomás JM, Jofre JT (1985) Lipopolysaccharide-specific bacteriophage for Klebsiella pneumoniae C3. J Bacteriol 162:1276–1279
Tumbarello M, Viale P, Viscoli C, Trecarichi EM, Tumietto F, Marchese A, Spanu T, Ambretti S, Ginocchio F, Cristini F, Losito AR, Tedeschi S, Cauda R, Bassetti M (2012) Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 55:943-50 . https://doi.org/10.1093/cid/cis588
Vading M, Nauclér P, Kalin M, Giske CG (2018) Invasive infection caused by Klebsiella pneumoniae is a disease affecting patients with high comorbidity and associated with high long-term mortality. PLoS One 13: . https://doi.org/10.1371/journal.pone.0195258
Verma V, Harjai K, Chhibber S (2009) Characterization of a T7-like lytic bacteriophage of Klebsiella pneumoniae B5055: a potential therapeutic agent. Curr Microbiol 59:274–281 . https://doi.org/10.1007/s00284-009-9430-y
Xie Y, Wahab L, Gill JJ (2018) Development and validation of a microtiter plate-based assay for determination of bacteriophage host range and virulence. Viruses 10: . https://doi.org/10.3390/v10040189
Zhao J, Zhang Z, Tian C, Chen X, Hu L, Wei X, Li H, Lin W, Jiang A, Feng R, Yuan J, Yin Z, Zhao X (2019) Characterizing the Biology of Lytic Bacteriophage vB_EaeM_φEap-3 Infecting Multidrug-Resistant Enterobacter aerogenes. Front Microbiol 10:420 . https://doi.org/10.3389/fmicb.2019.00420
(2017) Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities